Reflecting on AC26: conversations, collaboration…
Our Annual Conference 2026 brought together 345 knowledge transfer professionals from 42 countries for three days…
In a perfect world of licensing, TTOs may dream of a discovery licensed to a medical company, which continues developing it until it has established proof-of-concept in humans.Then a larger firm with the capability to conduct late-stage clinical trials comes in and carries the molecule to the market launch. It is an ideal scenerio that rarely plays out in real life. Instead, the path to the market is rough & laden with inefficiencies from funding to licencing agreements. The bad is that almost every early stage technology at the universities has to deal with these troubles all the time.
Meanwhile we also very often hear news about the commercialization success stories of MIT, Standford, Pittsburgh, University of Texas, Washington, Colombia etc. So, while some can’t make it, some can do. What is the MAGIC?
I conducted many interviews with the experts from these universities. There is not a formula which brings success but there are well planned strategies. Although these strategies vary depending on the culture of the university & TTO, here are some very essential points to keep in mind:
Source: bit.ly/1q7nhkW
Our Annual Conference 2026 brought together 345 knowledge transfer professionals from 42 countries for three days…
We are pleased to announce the release of the second edition of the Handbook for National Associations in Knowledge…
ASTP members have approved the new Board for 2026–2027, with Amanda Zeffman appointed President and Sally Cudmore…
Join our newsletter and get the latest news